Wealthy nations are purchasing vaccines against H5N1 influenza and boosting surveillance, but there are concerns that low-income countries will be left behind.
Wealthy nations are purchasing vaccines against H5N1 influenza and boosting surveillance, but there are concerns that low-income countries will be left behind.
This would work in the US if insurance companies did it.